APOE4 and early-onset Alzheimer’s @StanfordMedicine
APOE4 and early-onset Alzheimer’s  @StanfordMedicine
Uploaded September 2025 | Updated September 2026, 2 weeks ago
Alzheimer’s before 65 is called early onset. Stanford’s Dr. Michael Greicius explains how carrying the APOE4 gene may not only raise risk — but also speed up the disease.

Read more in Stanford Medicine magazine: https://stanmed.stanford.edu/alzheimers-variant-apoe4-new-drug-clues/

#alzheimers #alzheimersresearch #neuroscience
.
.
.
Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children's Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease.

The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.
APOE4 and early-onset Alzheimer’sAI In Bloom, A Three-Part Conversation, Part 1 – Innovations in CareShingles vaccine may reduce the risk of dementia | 90 Seconds w/ Lisa KimRAISE Health Seed Grant Recipient - Part 2 | Stanfords RAISE Health Symposium 2025The Big Idea: Exploring Transformative Breakthroughs with The Minor ConsultHealth Matters 2025 - Stanford Medicines Free Community DayHealth Compass | Season 2Walk With Me: Reena Thomas, Stanford neurooncologist & researcherFrontiers in Medicine 2024 | AI in Oncology: Predicting Cancer’s CourseGLP-1 weight-loss drugs: What the science says | 90 Seconds w/ Lisa KimJean Tang, MD ’99, PhD ’03, Resident ’07 | Personalized Gene Therapy to Treat Rare DiseaseBuilding a Model of Pain: Human Sensory Circuits in a Dish
Stanford Medicine |

APOE4 and early-onset Alzheimer’s

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER